Cancer
Rated high-performing in leukemia, lymphoma & myeloma, colon cancer surgery, lung cancer surgery, prostate cancer surgery, and more.
RESEARCH
Species-Specific ‘Shedding’ May Distort Testing of Cancer Drugs
A new study published in the Journal of Biological Chemistry from UC Davis Comprehensive Cancer Center finds that TIGIT (T cell immunoreceptor with Ig and ITIM domains) triggers a different response in rhesus macaques compared to humans. The study shows that rhesus macaques shed TIGIT from the surfaces of immune cells when exposed to plasmin.
Clinical Science
Gene Therapy Harnesses Viral Protein to Destroy Cancer Cells
A targeted gene therapy that kills cancer cells infected with Kaposi’s sarcoma-associated herpesvirus while sparing healthy tissue has been created by UC Davis researchers. The approach uses an adeno-associated virus to deliver a modified thymidine kinase enzyme, which activates ganciclovir into a cancer-killing agent in only infected cells.
RESEARCH
New Drug Developed at UC Davis Offers Hope for Bladder Cancer
UC Davis researchers have developed a novel drug that targets bladder cancer cells while minimizing side effects. The therapy showed promising results in preclinical studies, offering a potential new treatment option for patients. The research highlights UC Davis Health’s commitment to advancing cancer care through innovative approaches.
Education and Engagement
Latest News
Clinical Resources
Refer a Patient
We welcome the opportunity to partner with you in caring for your patient.
Browse Specialties
Our specialists are available when the need arises. Learn more about a specific health specialty.
Clinical Studies
The goal of clinical studies at UC Davis Health is to discover and share knowledge to advance health.
Awards and Recognitions
Ranked among the nation’s best hospitals
A U.S. News & World Report best hospital in cardiology, heart & vascular surgery, diabetes & endocrinology, ENT, geriatrics, neurology & neurosurgery, and pulmonology & lung surgery.
World-class cancer care
One of ~59 U.S. cancer centers designated “comprehensive” by the National Cancer Institute.
Member of the National Comprehensive Cancer Network
UC Davis Comprehensive Cancer Center is a member of the National Comprehensive Cancer Network, an alliance of the world’s leading cancer centers.
Accredited cancer programs
Cancer programs at UC Davis Comprehensive Cancer Center are accredited by the Commission on Cancer of the American College of Surgeons. Cancer programs, like those at the cancer center, voluntarily participate in the commission’s Approvals Program and meet 36 standards of quality patient care.
Ranked high-performing in leukemia, lymphoma & myeloma treatment
U.S. News & World Report rated UC Davis Medical Center high-performing in treating leukemia, lymphoma & myeloma.
Ranked high-performing in colon cancer surgery
U.S. News & World Report rated UC Davis Medical Center high-performing in colon cancer surgery.
Ranked high-performing in lung cancer surgery
U.S. News & World Report rated UC Davis Medical Center high-performing in lung cancer surgery.
Ranked high-performing in gynecological cancer surgery
U.S. News & World Report rated UC Davis Medical Center high-performing in gynecological cancer surgery.
Ranked high-performing in prostate cancer surgery
U.S. News & World Report rated UC Davis Medical Center high-performing in prostate cancer surgery.
Recognized as a hospital with a great oncology program
UC Davis Health has earned national recognition from Becker’s for their work in cancer care. Our programs offer leading-edge clinical trials and pioneer research discoveries that expand access to care and enhance patient outcomes.
The nation’s highest nursing honor
UC Davis Medical Center has received Magnet® recognition, the nation’s highest honor for nursing excellence.
Ranked Sacramento’s #1 hospital
Ranked Sacramento’s #1 hospital by U.S. News, and high-performing in aortic valve surgery, back surgery (spinal fusion), COPD, colon cancer surgery, diabetes, gynecological cancer surgery, heart arrhythmia, heart failure, kidney failure, leukemia, lymphoma & myeloma, lung cancer surgery, pacemaker implantation, pneumonia, prostate cancer surgery, stroke, TAVR, cancer, orthopedics, gastroenterology & GI surgery, and urology.